HIV care using differentiated service delivery during the COVID‐19 pandemic: a nationwide cohort study in the US Department of Veterans Affairs
Veterans Affairs
Pandemic
DOI:
10.1002/jia2.25810
Publication Date:
2021-10-29T05:36:29Z
AUTHORS (14)
ABSTRACT
The Department of Veterans Affairs (VA) is the largest provider HIV care in United States. Changes healthcare delivery became necessary with COVID-19 pandemic. We compared during first year pandemic to a prior similar calendar period.We included 27,674 people (PWH) enrolled Aging Cohort Study 1 March 2019, ≥1 encounter from 2019 29 February 2020 (2019) and/or 28 2021 (2020). counted monthly general medicine/infectious disease (GM/ID) clinic visits and HIV-1 RNA viral load (VL) tests. determined percentage visit (in-person vs. telephone/video [virtual]) VL test (detectable suppressed) for 2020. Using pharmacy records, we summarized antiretroviral (ARV) medication refill length (<90 ≥90 days) ARV coverage.Most patients had GM/ID (96%) (95%). For 27% were virtual 64% In 82% measured 74% Of those measured, 92% 91% suppressed refills days increased 39% 51% coverage was all months ranging 76% 80% except (72%). Women less likely than men be on ARVs or have both years.During pandemic, VA use longer refills, while maintaining high among measured. Despite decreased in-person services access not disrupted. More follow-up time needed determine whether overall health impacted by differentiated service evaluate long-term shift could beneficial, particularly PWH rural areas transportation barriers. Programmes increase testing women are needed.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (31)
CITATIONS (23)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....